Mega Lifesciences PCL (BKK:MEGA-R) Total Liabilities : ฿4,046 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Mega Lifesciences PCL Total Liabilities?

Mega Lifesciences PCL's Total Liabilities for the quarter that ended in Mar. 2025 was ฿4,046 Mil.

Mega Lifesciences PCL's quarterly Total Liabilities increased from Sep. 2024 (฿4,294.98 Mil) to Dec. 2024 (฿4,333.30 Mil) but then declined from Dec. 2024 (฿4,333.30 Mil) to Mar. 2025 (฿4,045.84 Mil).

Mega Lifesciences PCL's annual Total Liabilities declined from Dec. 2022 (฿5,869.71 Mil) to Dec. 2023 (฿4,812.68 Mil) and declined from Dec. 2023 (฿4,812.68 Mil) to Dec. 2024 (฿4,333.30 Mil).

Mega Lifesciences PCL Total Liabilities Historical Data

The historical data trend for Mega Lifesciences PCL's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mega Lifesciences PCL Total Liabilities Chart

Mega Lifesciences PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

4,577.90

5,246.58

5,869.71

4,812.68

4,333.30

Mega Lifesciences PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															4,414.61	5,176.18	4,294.98	4,333.30	4,045.84

Mega Lifesciences PCL Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Mega Lifesciences PCL's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3914.314	+	(139.826	+	1.1368683772162E-13
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	1.048	+	278.111	+	0)
	=	4,333

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	14210.134	-	9876.835
	=	4,333

Mega Lifesciences PCL's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	3610.552	+	(146.358	+	-1.1368683772162E-13
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0.001	+	288.926	+	0)
	=	4,046

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	14364.102	-	10318.265
	=	4,046

Mega Lifesciences PCL Total Liabilities Related Terms

Thank you for viewing the detailed overview of Mega Lifesciences PCL's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Mega Lifesciences PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mega Lifesciences PCL (BKK:MEGA-R) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MEGA:Thailand

Address

Debaratna Road, 909, Ample Tower, 9th Floor, Bangna Nuea, Bangna, Bangkok, THA, 10260

Website

https://www.megawecare.com

Mega Lifesciences PCL manufactures and sells through independent distributors of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods as well as provides distribution services relating to such products. The company's product portfolio consists of health food supplements, branded prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods. Its segments include Brands in which goods are manufactured and sold under brands owned by the group; Distribution in which the group provides logistical and marketing services for goods trading purposes and sale of goods manufactured by third parties; and OEM.

Mega Lifesciences PCL Headlines

No Headlines